SOURCE: I-many


November 17, 2009 11:35 ET

I-many to Host Health Care Reform Symposium

Event to Explore Health Care Reform's Impact on the Pharmaceutical Industry

PHILADELPHIA, PA--(Marketwire - November 17, 2009) - I-many, Inc., the leading provider of Contract Lifecycle Management enterprise software and solutions to optimize revenue within the bounds of compliance, is pleased to announce an exclusive event on December 8th to discuss Health Care Reform and its potential impact on the pharmaceutical industry. Taking place at the Pyramid Club Philadelphia, the event will bring together dozens of executives from major pharmaceutical firms to exchange ideas and hear from industry experts.

The keynote speaker will be Edith S. Marshall, Counsel with Arnold & Porter LLP, an international law firm with a leading practice in Medicare, Medicaid, and Public Health issues, including drug pricing and contracting, compliance, litigation, and reimbursement. Ms. Marshall, whose past professional roles include attorney for CMS, Senior Trial Attorney with the US Department of Justice, Assistant United States Attorney, and Director of Legal Affairs for a hospital trade association, has extensive experience in administrative law and federal programs, especially Medicare, Medicaid, and other programs relating to public health. In her current practice, Ms. Marshall counsels and represents clients on a wide range of matters involving Medicare and Medicaid, drug pricing, regulatory compliance, fraud and abuse, and HIPAA privacy and security. Representing individuals, government agencies, and private corporate entities, she has litigated numerous cases in the federal courts involving coverage and payment in federal healthcare programs, information and privacy, and a broad range of other issues arising under federal laws and regulations.

During this event, representatives from major pharmaceutical firms will participate in roundtable discussions with industry experts on topics such as:

--  Impact of the expansion of Medicaid, 340B, and other government
    programs on pharmaceutical demand and profitability
--  Best practices in protecting profits through strategic contracting and
    enhanced data validation
--  How I-many is responding to these changes with its current and future
    solution offerings

According to P. Kevin Kilroy, President and CEO of I-many, "As the House and Senate craft legislation that will shape the future of the pharmaceutical industry, I-many is committed to staying abreast of these changes. The expansions of the Medicaid and 340B programs, new reimbursement methodologies, and growing compliance concerns make it increasingly challenging for manufacturers to stay competitive. I-many is focused on helping the industry adapt to this new era with technology that will ease the transition with better visibility and analysis tools and a flexible, configurable compliance framework."

To register for this event, please go to or call 215-344-1900.

About I-many®

I-many is the leading provider of contract lifecycle management software and services for the enterprise within the life sciences industry as well as other sectors that must manage complex contractual relationships integral to their core business. With 23 of the top 25 life sciences companies and hundreds of organizations across 21 industries worldwide, I-many enables businesses to manage the entire contract life cycle, from pre-contract processes and contract management to active compliance, contract optimization, demand channel visibility and control. The result is an end-to-end solution that provides greater levels of insight into contract performance and regulatory compliance allowing companies to improve profitability and achieve a significant measurable return on investment within a very short timeframe. For more information, please visit

Contact Information

  • Press Contact:
    I-many, Inc.
    Jerry Inman
    Email Contact